Olaplex (OLPX) Form 144: 108,335 Shares Proposed Sale on 08/14/2025

Olaplex Holdings, Inc. (OLPX) filed a Form 144 reporting a proposed sale of 108,335 common shares through Morgan Stanley Smith Barney LLC, scheduled approximately 08/14/2025 on NASDAQ.

Rhea-AI Filing Summary

Olaplex Holdings, Inc. (OLPX) filed a Form 144 reporting a proposed sale of 108,335 common shares through Morgan Stanley Smith Barney LLC, scheduled approximately 08/14/2025 on NASDAQ. The filing states these shares were acquired as restricted stock units on 08/13/2025 and were paid as compensation; the aggregate market value is $158,167.16 and the issuer’s shares outstanding are listed as 667,081,086, so the sale represents about 0.016% of outstanding stock. No securities were reported sold by the filer in the past three months. The filer affirms they are not aware of any undisclosed material adverse information.

Insights

Securities Analyst

TL;DR Routine RSU-origin sale; size is immaterial relative to outstanding shares.

The Form 144 discloses a proposed sale of 108,335 common shares with an aggregate market value of $158,167.16. These shares were acquired as restricted stock units on 08/13/2025 and are to be sold via Morgan Stanley Smith Barney LLC on or about 08/14/2025. The sale equals roughly 0.016% of the reported 667,081,086 shares outstanding, indicating a negligible immediate market impact and consistent with a compensatory liquidity event.

Corporate Governance Expert

TL;DR Disclosure aligns with standard compliance; filer confirms no undisclosed material information.

The filing includes the required representation that the person for whose account the shares will be sold does not possess material nonpublic information. It also notes that the securities were compensation-related restricted stock units and that there were no reported sales by the filer in the prior three months. Documentation appears to follow Rule 144 and Form 144 disclosure norms.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Olaplex (OLPX) report in the Form 144?

The filing reports a proposed sale of 108,335 common shares via Morgan Stanley Smith Barney LLC with an aggregate market value of $158,167.16.

When is the proposed sale date for the OLPX shares?

The approximate date of sale is listed as 08/14/2025.

How were the shares acquired that are being sold?

The shares were acquired on 08/13/2025 as Restricted Stock Units and the nature of payment is listed as compensation.

How many Olaplex shares are outstanding according to the filing?

The filing reports 667,081,086 shares outstanding.

Did the filer report any sales in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2025 - 02:53 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001448918
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OLAPLEX HOLDINGS, INC.
SEC File Number	001-40860
Address of Issuer	432 PARK AVENUE SOUTH THIRD FLOOR NEW YORK NEW YORK 10016
Phone	310-691-0776
Name of Person for Whose Account the Securities are To Be Sold	Dunleavy Catherine
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Services 200 W Civic Center Dr - 4th Floor Sandy UT 84070	108335	158167.16	667081086	08/14/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/13/2025	Restricted Stock Units	Issuer			108335	08/13/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Catherine Dunleavy
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)